Hebert, A., R. Schrieber, D. Glaab, and L. Eichenfield. “Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol Propionate Foam, 0.05% in Adolescent Subjects With Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s77, doi:10.25251/skin.4.supp.77.